LIGS 2.0 introduces a new screening method to selectively identify synthetic ligands against cell-surface proteins in order to expand the repertoire of immunotherapeutic molecules against life-threatening diseases such as cancer and auto-immune diseases.
| Accession | PRJNA523255 |
| Data Type | Raw sequence reads |
| Scope | Multispecies |
| Grants | - "Ligand Guided Selection of Aptamers against Human Leukemia and Lymphoma" (Grant ID SC1 GM122648, National Institute of General Medical Sciences)
|
| Submission | Registration date: 19-Feb-2019
Lehman College,CUNY |
| Relevance | Medical |
Project Data:
| Resource Name | Number
of Links |
|---|
| Sequence data |
| SRA Experiments | 32 |
| Other datasets |
| BioSample | 1 |